Companies › AXSM

AXSOME THERAPEUTICS INC. (AXSM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001579428 · EDGAR filings · Updated 2026-07-27

AXSOME THERAPEUTICS INC. (AXSM) has reported institutional ownership of 73.7%, with 409 institutional managers holding positions valued at $6.41B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-15 — Current report (8-K) filed
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)
• 2026-06-11 — Insider transaction reported (Form 4)
• 2026-06-11 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AXSOME THERAPEUTICS INC. has 409 institutional holders and institutional ownership of 73.7%.

Insider activity

Insiders reported 82 transactions (3 buys, 43 sells) across 8 reporting insiders, with a net reported value of −$128.2M.

Related companies

SCHOLAR ROCK HLDG CORP (SRRK) · PTC THERAPEUTICS INC (PTCT) · RHYTHM PHARMACEUTICALS INC COM (RYTM) · MIRUM PHARMACEUTICALS INC (MIRM) · GLAUKOS CORP (GKOS) · ALKERMES PLC (ALKS)